Medgend Icon

Ledgend of Medicine







discontinued


Erlotinib Hydrochloride FDA Approved Drugs

TARCEVA [Erlotinib HydrochlorideC22H23N3O4ClH]
RX
-
eq 100mg base (oral tablet)
eq 150mg base (oral tablet)
eq 25mg base (oral tablet)
Osi PharmsNov 18, 2004
  • First-line treatment of locally advanced unresectable or metastatic pancreatic cancer, in combination with gemcitabine.
  • First-line treatment of metastatic non smal-cell lung cancer (nsclc) with egfr exon 19 deletions or exon 21 (l858r) substitution mutations as detected by an fda-approved test.
  • Maintenance treatment in patients with locally advanced or metastatic nsclc who have not progressed on 1st-line treatment wth platinum-based chemotherapy.
  • Maintenance treatment of patients with locally advanced or metastatic nsclc whose disease has not progressed after four cycles platinum-based chemotherapy.
  • Treatment of locally advanced or metastatic non small-cell lung cancer (nsclc) after failure of at least one prior chemotherapy regimen.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.